questionsmedicales.fr
Actions chimiques et utilisations
Actions pharmacologiques
Effets physiologiques des médicaments
Hypoglycémiants
Hypoglycémiants : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Hypoglycémie
Diabète
Glycémie
Diabète
Glycémie
Test de tolérance au glucose
Hypoglycémie
Symptômes
Palpitations
Hypoglycémie
Consultation médicale
Symptômes
Symptômes
5
Hypoglycémie
Fatigue
Irritabilité
Hypoglycémie
Convulsions
Coma
Hypoglycémie
Sensibilité
Symptômes
Hypoglycémie
Intervention médicale
Symptômes
Prévention
5
Prévention
Hypoglycémie
Alimentation
Exercice
Prévention
Glycémie
Surveillance
Glycémie
Prévention
Éducation
Hypoglycémie
Symptômes
Régime alimentaire
Hypoglycémie
Glycémie
Traitements
5
Hypoglycémiants
Metformine
Sulfonylurées
Hypoglycémie
Glucose
Administration intraveineuse
Hypoglycémiants
Effets secondaires
Nausées
Hypoglycémiants
Ajustement du traitement
Glycémie
Hypoglycémiants
Diabète
Efficacité
Complications
5
Hypoglycémie
Complications
Accidents vasculaires cérébraux
Hypoglycémie
Séquelles
Neurologique
Hypoglycémie
Qualité de vie
Anxiété
Complications
Hypoglycémie
Traitement
Hypoglycémie
Risques à long terme
Cardiovasculaire
Facteurs de risque
5
Hypoglycémie
Facteurs de risque
Diabète
Âge
Hypoglycémie
Sensibilité
Antécédents familiaux
Diabète
Hypoglycémie
Stress
Hypoglycémie
Glycémie
Médicaments
Hypoglycémie
Bêta-bloquants
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hypoglycémiants : Questions médicales les plus fréquentes",
"headline": "Hypoglycémiants : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hypoglycémiants : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-16",
"dateModified": "2025-03-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hypoglycémiants"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Effets physiologiques des médicaments",
"url": "https://questionsmedicales.fr/mesh/D045505",
"about": {
"@type": "MedicalCondition",
"name": "Effets physiologiques des médicaments",
"code": {
"@type": "MedicalCode",
"code": "D045505",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Inhibiteurs des glycoside hydrolases",
"alternateName": "Glycoside Hydrolase Inhibitors",
"url": "https://questionsmedicales.fr/mesh/D065089",
"about": {
"@type": "MedicalCondition",
"name": "Inhibiteurs des glycoside hydrolases",
"code": {
"@type": "MedicalCode",
"code": "D065089",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.422.249"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Agonistes des récepteurs de l'amyline",
"alternateName": "Amylin Receptor Agonists",
"url": "https://questionsmedicales.fr/mesh/D065091",
"about": {
"@type": "MedicalCondition",
"name": "Agonistes des récepteurs de l'amyline",
"code": {
"@type": "MedicalCode",
"code": "D065091",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.422.374"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Inhibiteurs de la dipeptidyl-peptidase IV",
"alternateName": "Dipeptidyl-Peptidase IV Inhibitors",
"url": "https://questionsmedicales.fr/mesh/D054873",
"about": {
"@type": "MedicalCondition",
"name": "Inhibiteurs de la dipeptidyl-peptidase IV",
"code": {
"@type": "MedicalCode",
"code": "D054873",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.422.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Secrétagogues à l'insuline",
"alternateName": "Insulin Secretagogues",
"url": "https://questionsmedicales.fr/mesh/D000092005",
"about": {
"@type": "MedicalCondition",
"name": "Secrétagogues à l'insuline",
"code": {
"@type": "MedicalCode",
"code": "D000092005",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.422.625"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Agonistes du PPAR gamma",
"alternateName": "PPAR-gamma Agonists",
"url": "https://questionsmedicales.fr/mesh/D000092126",
"about": {
"@type": "MedicalCondition",
"name": "Agonistes du PPAR gamma",
"code": {
"@type": "MedicalCode",
"code": "D000092126",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.422.688"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Inhibiteurs du cotransporteur sodium-glucose de type 2",
"alternateName": "Sodium-Glucose Transporter 2 Inhibitors",
"url": "https://questionsmedicales.fr/mesh/D000077203",
"about": {
"@type": "MedicalCondition",
"name": "Inhibiteurs du cotransporteur sodium-glucose de type 2",
"code": {
"@type": "MedicalCode",
"code": "D000077203",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.422.750"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Hypoglycémiants",
"alternateName": "Hypoglycemic Agents",
"code": {
"@type": "MedicalCode",
"code": "D007004",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Nunzio Cardullo",
"url": "https://questionsmedicales.fr/author/Nunzio%20Cardullo",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Giuseppe Floresta",
"url": "https://questionsmedicales.fr/author/Giuseppe%20Floresta",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Vera Muccilli",
"url": "https://questionsmedicales.fr/author/Vera%20Muccilli",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Antonio Rescifina",
"url": "https://questionsmedicales.fr/author/Antonio%20Rescifina",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Corrado Tringali",
"url": "https://questionsmedicales.fr/author/Corrado%20Tringali",
"affiliation": {
"@type": "Organization",
"name": ""
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Implementation and Consensus.",
"datePublished": "2024-08-19",
"url": "https://questionsmedicales.fr/article/39149952",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/IJG.0000000000002439"
}
},
{
"@type": "ScholarlyArticle",
"name": "International Consensus on Standard Outcome Measures for Neurodevelopmental Disorders: A Consensus Statement.",
"datePublished": "2024-06-03",
"url": "https://questionsmedicales.fr/article/38869906",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1001/jamanetworkopen.2024.16760"
}
},
{
"@type": "ScholarlyArticle",
"name": "Expert consensus on oncological [",
"datePublished": "2022-06-25",
"url": "https://questionsmedicales.fr/article/35751696",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00330-022-08960-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Consensus and inconsistency between different consensus documents on renal denervation worldwide: the way forward.",
"datePublished": "2022-12-20",
"url": "https://questionsmedicales.fr/article/36103983",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/CM9.0000000000002109"
}
},
{
"@type": "ScholarlyArticle",
"name": "Screening of Glaucoma: Consensus and Directions.",
"datePublished": "2024-06-14",
"url": "https://questionsmedicales.fr/article/39149954",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/IJG.0000000000002449"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Actions chimiques et utilisations",
"item": "https://questionsmedicales.fr/mesh/D020164"
},
{
"@type": "ListItem",
"position": 3,
"name": "Actions pharmacologiques",
"item": "https://questionsmedicales.fr/mesh/D020228"
},
{
"@type": "ListItem",
"position": 4,
"name": "Effets physiologiques des médicaments",
"item": "https://questionsmedicales.fr/mesh/D045505"
},
{
"@type": "ListItem",
"position": 5,
"name": "Hypoglycémiants",
"item": "https://questionsmedicales.fr/mesh/D007004"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hypoglycémiants - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hypoglycémiants",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hypoglycémiants",
"description": "Comment diagnostiquer une hypoglycémie ?\nQuels tests sont utilisés pour le diabète ?\nQuels symptômes indiquent une hypoglycémie ?\nQuand consulter un médecin pour hypoglycémie ?\nQuel rôle joue l'HbA1c dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D007004?mesh_terms=Consensus#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hypoglycémiants",
"description": "Quels sont les signes d'une hypoglycémie ?\nComment reconnaître une hypoglycémie sévère ?\nLes symptômes varient-ils selon les personnes ?\nQuels symptômes nécessitent une intervention rapide ?\nLes symptômes peuvent-ils être confondus avec d'autres ?",
"url": "https://questionsmedicales.fr/mesh/D007004?mesh_terms=Consensus#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hypoglycémiants",
"description": "Comment prévenir l'hypoglycémie ?\nQuel rôle joue l'exercice dans la prévention ?\nLes patients doivent-ils surveiller leur glycémie ?\nComment éduquer les patients sur l'hypoglycémie ?\nLes régimes alimentaires peuvent-ils aider ?",
"url": "https://questionsmedicales.fr/mesh/D007004?mesh_terms=Consensus#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hypoglycémiants",
"description": "Quels sont les principaux hypoglycémiants ?\nComment administrer du glucose en cas d'hypoglycémie ?\nQuels sont les effets secondaires des hypoglycémiants ?\nComment ajuster le traitement hypoglycémiant ?\nLes hypoglycémiants sont-ils efficaces pour tous ?",
"url": "https://questionsmedicales.fr/mesh/D007004?mesh_terms=Consensus#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hypoglycémiants",
"description": "Quelles sont les complications de l'hypoglycémie ?\nL'hypoglycémie peut-elle entraîner des séquelles ?\nComment l'hypoglycémie affecte-t-elle la qualité de vie ?\nLes complications sont-elles réversibles ?\nQuels sont les risques à long terme de l'hypoglycémie ?",
"url": "https://questionsmedicales.fr/mesh/D007004?mesh_terms=Consensus#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hypoglycémiants",
"description": "Quels sont les facteurs de risque d'hypoglycémie ?\nL'âge influence-t-il le risque d'hypoglycémie ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe stress peut-il aggraver l'hypoglycémie ?\nLes médicaments peuvent-ils influencer le risque ?",
"url": "https://questionsmedicales.fr/mesh/D007004?mesh_terms=Consensus#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une hypoglycémie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hypoglycémie est diagnostiquée par des tests de glycémie inférieure à 70 mg/dL."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diabète ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent la glycémie à jeun, l'HbA1c et le test de tolérance au glucose."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une hypoglycémie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent tremblements, sueurs, confusion et palpitations."
}
},
{
"@type": "Question",
"name": "Quand consulter un médecin pour hypoglycémie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consultez un médecin si les symptômes persistent ou s'aggravent."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'HbA1c dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'HbA1c évalue le contrôle glycémique sur 2-3 mois, utile pour le diagnostic du diabète."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'une hypoglycémie ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent fatigue, irritabilité, faim intense et vertiges."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une hypoglycémie sévère ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une hypoglycémie sévère peut provoquer des convulsions, une perte de conscience ou un coma."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon les personnes ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier d'une personne à l'autre en fonction de la sensibilité."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent une intervention rapide ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes graves comme confusion, convulsions ou perte de conscience nécessitent une aide immédiate."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils être confondus avec d'autres ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être confondus avec ceux d'autres conditions comme l'anxiété ou l'AVC."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'hypoglycémie ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Prévenir l'hypoglycémie nécessite une alimentation équilibrée et un suivi régulier de la glycémie."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'exercice dans la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exercice régulier aide à réguler la glycémie et à prévenir les épisodes d'hypoglycémie."
}
},
{
"@type": "Question",
"name": "Les patients doivent-ils surveiller leur glycémie ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la surveillance régulière de la glycémie est essentielle pour prévenir l'hypoglycémie."
}
},
{
"@type": "Question",
"name": "Comment éduquer les patients sur l'hypoglycémie ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'éducation doit inclure la reconnaissance des symptômes et les mesures à prendre en cas d'hypoglycémie."
}
},
{
"@type": "Question",
"name": "Les régimes alimentaires peuvent-ils aider ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un régime alimentaire équilibré et riche en fibres peut aider à stabiliser la glycémie."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux hypoglycémiants ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux hypoglycémiants incluent la metformine, les sulfonylurées et les inhibiteurs DPP-4."
}
},
{
"@type": "Question",
"name": "Comment administrer du glucose en cas d'hypoglycémie ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le glucose peut être administré par voie orale ou intraveineuse selon la gravité."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des hypoglycémiants ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des nausées, des diarrhées et des hypoglycémies."
}
},
{
"@type": "Question",
"name": "Comment ajuster le traitement hypoglycémiant ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement doit être ajusté en fonction des niveaux de glycémie et des symptômes."
}
},
{
"@type": "Question",
"name": "Les hypoglycémiants sont-ils efficaces pour tous ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, leur efficacité peut varier selon le type de diabète et la réponse individuelle."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications de l'hypoglycémie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles neurologiques, des accidents vasculaires cérébraux et des chutes."
}
},
{
"@type": "Question",
"name": "L'hypoglycémie peut-elle entraîner des séquelles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des épisodes répétés peuvent causer des dommages neurologiques permanents."
}
},
{
"@type": "Question",
"name": "Comment l'hypoglycémie affecte-t-elle la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hypoglycémie fréquente peut entraîner une anxiété accrue et une diminution de la qualité de vie."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles si l'hypoglycémie est traitée rapidement."
}
},
{
"@type": "Question",
"name": "Quels sont les risques à long terme de l'hypoglycémie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques à long terme incluent des troubles cognitifs et une augmentation du risque cardiovasculaire."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque d'hypoglycémie ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent un traitement intensif du diabète, une alimentation irrégulière et l'alcool."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'hypoglycémie ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées sont plus susceptibles de souffrir d'hypoglycémie en raison de la sensibilité accrue."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de diabète peuvent augmenter le risque d'hypoglycémie."
}
},
{
"@type": "Question",
"name": "Le stress peut-il aggraver l'hypoglycémie ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut affecter la glycémie et augmenter le risque d'hypoglycémie."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils influencer le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments, comme les bêta-bloquants, peuvent masquer les symptômes d'hypoglycémie."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 11/03/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Publications dans "Hypoglycémiants" :
2 publications dans cette catégorie
Publications dans "Hypoglycémiants" :
2 publications dans cette catégorie
Publications dans "Hypoglycémiants" :
2 publications dans cette catégorie
Publications dans "Hypoglycémiants" :
2 publications dans cette catégorie
Publications dans "Hypoglycémiants" :
2 publications dans cette catégorie
Affiliations :
Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Beihang University, Beijing, China.
Publications dans "Hypoglycémiants" :
2 publications dans cette catégorie
Affiliations :
Elderly Health Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Publications dans "Hypoglycémiants" :
2 publications dans cette catégorie
Affiliations :
College of Food Science and Engineering, Northwest A&F University, Yangling, China.
Publications dans "Hypoglycémiants" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical Pharmacy, King Khalid University, Abha, Saudi Arabia.
Publications dans "Hypoglycémiants" :
1 publication dans cette catégorie
Affiliations :
State Key Laboratory of Food Science and Technology, School of Food Science and Technology, Jiangnan University, 1800 Lihu Avenue, Wuxi, Jiangsu 214122, P.R. China and National Engineering Research Center for Functional Food, Jiangnan University, 1800 Lihu Avenue, Wuxi, Jiangsu 214122, P.R. China and Collaborative Innovation Center of Food Safety and Quality Control in Jiangsu Province, Jiangnan University, 1800 Lihu Avenue, Wuxi, Jiangsu 214122, P.R. China. shuhuai@jiangnan.edu.cn zhaow@jiangnan.edu.cn.
Publications dans "Hypoglycémiants" :
1 publication dans cette catégorie
Affiliations :
State Key Laboratory of Food Science and Technology, School of Food Science and Technology, Jiangnan University, 1800 Lihu Avenue, Wuxi, Jiangsu 214122, P.R. China and National Engineering Research Center for Functional Food, Jiangnan University, 1800 Lihu Avenue, Wuxi, Jiangsu 214122, P.R. China and Collaborative Innovation Center of Food Safety and Quality Control in Jiangsu Province, Jiangnan University, 1800 Lihu Avenue, Wuxi, Jiangsu 214122, P.R. China. shuhuai@jiangnan.edu.cn zhaow@jiangnan.edu.cn.
Publications dans "Hypoglycémiants" :
1 publication dans cette catégorie
Affiliations :
State Key Laboratory of Food Science and Technology, School of Food Science and Technology, Jiangnan University, 1800 Lihu Avenue, Wuxi, Jiangsu 214122, P.R. China and National Engineering Research Center for Functional Food, Jiangnan University, 1800 Lihu Avenue, Wuxi, Jiangsu 214122, P.R. China and Collaborative Innovation Center of Food Safety and Quality Control in Jiangsu Province, Jiangnan University, 1800 Lihu Avenue, Wuxi, Jiangsu 214122, P.R. China. shuhuai@jiangnan.edu.cn zhaow@jiangnan.edu.cn.
Publications dans "Hypoglycémiants" :
1 publication dans cette catégorie
Affiliations :
State Key Laboratory of Food Science and Technology, School of Food Science and Technology, Jiangnan University, 1800 Lihu Avenue, Wuxi, Jiangsu 214122, P.R. China and National Engineering Research Center for Functional Food, Jiangnan University, 1800 Lihu Avenue, Wuxi, Jiangsu 214122, P.R. China and Collaborative Innovation Center of Food Safety and Quality Control in Jiangsu Province, Jiangnan University, 1800 Lihu Avenue, Wuxi, Jiangsu 214122, P.R. China. shuhuai@jiangnan.edu.cn zhaow@jiangnan.edu.cn.
Publications dans "Hypoglycémiants" :
1 publication dans cette catégorie
Affiliations :
Steno Diabetes Center North Jutland, Aalborg University Hospital, Aalborg, Aalborg, Denmark.
Publications dans "Hypoglycémiants" :
1 publication dans cette catégorie
Affiliations :
Department of Anesthesiology, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
Publications dans "Hypoglycémiants" :
1 publication dans cette catégorie
Affiliations :
Department of Anesthesiology, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA. Electronic address: angela.selzer@cuanschutz.edu.
Publications dans "Hypoglycémiants" :
1 publication dans cette catégorie
Publications dans "Hypoglycémiants" :
1 publication dans cette catégorie
Publications dans "Hypoglycémiants" :
1 publication dans cette catégorie
Publications dans "Hypoglycémiants" :
1 publication dans cette catégorie
Affiliations :
Rutgers Robert Wood Johnson Medical School, Piscataway, NJ, USA.
Publications dans "Hypoglycémiants" :
The use of evidence-based standardized outcome measures is increasingly recognized as key to guiding clinical decision-making in mental health. Implementation of these measures into clinical practice ...
To develop a core set of outcome measures for specific neurodevelopmental disorders (NDDs), such as attention-deficit/hyperactivity disorder (ADHD), communication disorders, specific learning disorder...
An international working group composed of clinical and research experts and service users (n = 27) was convened to develop a standard core set of accessible, valid, and reliable outcome measures for ...
The final set recommends measuring 12 outcomes across 3 key domains: (1) core symptoms related to the diagnosis; (2) impact, functioning, and quality of life; and (3) common coexisting problems. The f...
The NDD set covers outcomes of most concern to patients and caregivers. Use of the NDD set has the potential to improve clinical practice and research....
[...
The consensus was summarized based on the published guidelines and peer-reviewed articles of TB PET/CT in the literature, along with the opinions of the experts from major research institutions with a...
This consensus describes the protocols for routine and dynamic [...
This expert consensus focuses on the reduction of acquisition time and FDG injected activity with a TB PET/CT scanner, which may improve the patient throughput or reduce the radiation exposure in dail...
• [...
Given the unsatisfactory hypertension control rates and high rates of non-adherence to antihypertensive medications worldwide, device therapy which can safely provide durable blood pressure-lowering e...
Glaucoma is a leading public health concern globally. This summary discusses barriers to glaucoma screening and novel strategies for a cost-effective glaucoma screening....
We discuss barriers to glaucoma screening and recent advancements in glaucoma detection and care, including targeted screening approach as well as telemedicine, genetic testing, and artificial intelli...
Screening of glaucoma is challenging and changing. Recent advancements in digital technology and genetics have led to the development of tools that are promising for novel screening methodologies. Cli...
Hernia repairs are a commonly performed surgical procedure and the Shouldice Repair of inguinal hernias has been well described before in terms of its outcomes. However, the purpose of this paper was ...
Utilizing a Delphi Methodology, surgeons at Shouldice Hospital who are considered content experts, provided their answers on what is essential to the Shouldice Method. The median, interquartile range,...
The final consensus for the Shouldice Method included 39 items with 7 overarching steps: preoperative preparation of the patient, anesthetic component, incision and nerve identification, treatment of ...
The results of this consensus provide a step-by-step approach to the Shouldice Method, as well as information that is timely and can be utilized by surgeons incorporating non-mesh hernia repairs into ...
Multiview subspace learning has attracted much attention due to the efficacy of exploring the information on multiview features. Most existing methods perform data reconstruction on the original featu...
Cryo-EM particle identification from micrographs ("picking") is challenging due to the low signal-to-noise ratio and lack of ground truth for particle locations. State-of-the-art computational algorit...
Using an expert consensus-based approach, a netball video analysis consensus (NVAC) group of researchers and practitioners was formed to develop a video analysis framework of descriptors and definitio...
The rapid adoption of robotic surgical systems across Europe has led to a critical gap in training and credentialing for gastrointestinal (GI) surgeons. Currently, there is no existing standardised cu...
In Stage 1, a Steering Committee, consisting of international experts, trainees and educationalists, has been established to lead and coordinate the consensus development process. In Stage 2, a system...
The study protocol has been registered on the Open Science Framework (https://osf.io/br87d/)....